133 related articles for article (PubMed ID: 31393163)
1. Poor survival of non-small-cell lung cancer patients with main bronchus tumor: a large population-based study.
Li C; Liu J; Lin J; Li Z; Shang X; Wang H
Future Oncol; 2019 Aug; 15(24):2819-2827. PubMed ID: 31393163
[No Abstract] [Full Text] [Related]
2. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
Shang X; Liu J; Li Z; Lin J; Wang H
BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
[TBL] [Abstract][Full Text] [Related]
3. Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes.
Shaverdian N; Veruttipong D; Wang J; Kupelian P; Steinberg M; Lee P
Clin Lung Cancer; 2017 Mar; 18(2):e137-e142. PubMed ID: 27908620
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and prognosis of resected T3 non-small cell lung cancer.
Riquet M; Lang-Lazdunski L; Le PB; Dujon A; Souilamas R; Danel C; Manac'h D
Ann Thorac Surg; 2002 Jan; 73(1):253-8. PubMed ID: 11834019
[TBL] [Abstract][Full Text] [Related]
5. Reassessment of Right Middle Lobe Lung Cancer: Comparison of Segments 4 and 5 Tumors.
Handa Y; Tsutani Y; Ikeda T; Hanaki H; Miyata Y; Mukaida H; Okada M
Ann Thorac Surg; 2018 May; 105(5):1543-1550. PubMed ID: 29329989
[TBL] [Abstract][Full Text] [Related]
6. T1/T2 non-small-cell lung cancer treated by lobectomy: does tumor anatomic location matter?
Whitson BA; Groth SS; Andrade RS; Habermann EB; Maddaus MA; D'Cunha J
J Surg Res; 2012 Oct; 177(2):185-90. PubMed ID: 22921916
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation.
Pujol JL; Parrat E; Lehmann M; Gautier V; Daurès JP; Michel FB; Godard P
Am J Respir Crit Care Med; 1996 Jan; 153(1):243-9. PubMed ID: 8542123
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
Ito M; Yamashita Y; Miyata Y; Ohara M; Tsutani Y; Ikeda T; Misumi K; Harada H; Omori K
Lung Cancer; 2012 Apr; 76(1):93-7. PubMed ID: 22285532
[TBL] [Abstract][Full Text] [Related]
10. Tumor location is not an independent prognostic factor in early stage non-small cell lung cancer.
Puri V; Garg N; Engelhardt EE; Kreisel D; Crabtree TD; Meyers BF; Patterson GA; Krupnick AS
Ann Thorac Surg; 2010 Apr; 89(4):1053-9. PubMed ID: 20338306
[TBL] [Abstract][Full Text] [Related]
11. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
[TBL] [Abstract][Full Text] [Related]
12. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the non-small cell lung cancer patients with bronchus involvements: A population-based study.
Wang G; Ye YQ; Xie BL; Lai XM; Zhong SP
Clin Respir J; 2023 Sep; 17(9):941-950. PubMed ID: 37545476
[TBL] [Abstract][Full Text] [Related]
14. Local extension at the hilum region is associated with worse long-term survival in stage I non-small cell lung cancers.
Chen C; Bao F; Zheng H; Zhou YM; Bao MW; Xie HK; Jiang GN; Ding JA; Gao W
Ann Thorac Surg; 2012 Feb; 93(2):389-96. PubMed ID: 22206959
[TBL] [Abstract][Full Text] [Related]
15. Location of stage I-III non-small cell lung cancer and survival rate: Systematic review and meta-analysis.
Lee HW; Lee CH; Park YS
Thorac Cancer; 2018 Dec; 9(12):1614-1622. PubMed ID: 30259691
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of microscopic proximal bronchial extension in non-small cell lung cancer.
Kara M; Dikmen E; Kiliç D; Sak SD; Orhan D; Köse SK; Kavukçu S
Ann Thorac Surg; 2002 Aug; 74(2):348-54. PubMed ID: 12173812
[TBL] [Abstract][Full Text] [Related]
17. Survival and risk model for stage IB non-small cell lung cancer.
Padilla J; Calvo V; Peñalver JC; Zarza AG; Pastor J; Blasco E; París F
Lung Cancer; 2002 Apr; 36(1):43-8. PubMed ID: 11891032
[TBL] [Abstract][Full Text] [Related]
18. Basaloid bronchial carcinoma. A histologic group with a poor prognosis.
Moro D; Brichon PY; Brambilla E; Veale D; Labat F; Brambilla C
Cancer; 1994 Jun; 73(11):2734-9. PubMed ID: 8194014
[TBL] [Abstract][Full Text] [Related]
19. Significance of lymphangiosis carcinomatosa at the bronchial resection margin in patients with non-small cell lung cancer.
Passlick B; Sitar I; Sienel W; Thetter O; Morresi-Hauf A
Ann Thorac Surg; 2001 Oct; 72(4):1160-4. PubMed ID: 11603430
[TBL] [Abstract][Full Text] [Related]
20. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
Robinson BM; Kennedy C; McLean J; McCaughan BC
J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
